scAAV9/AGA gene therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for scAAV9/AGA gene therapy, covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of scAAV9/AGA Gene Therapy in Participants With Aspartylglucosaminuria (AGU) [Phase 1, Phase 2]